GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $27,360,000 | +68.3% | 1,144,775 | +2.8% | 0.00% | +33.3% |
Q4 2020 | $16,259,000 | -4.9% | 1,113,654 | -7.5% | 0.00% | 0.0% |
Q3 2020 | $17,090,000 | -1.5% | 1,203,543 | +2.0% | 0.00% | -25.0% |
Q2 2020 | $17,350,000 | +431.1% | 1,179,547 | +48.7% | 0.00% | +300.0% |
Q1 2020 | $3,267,000 | -55.4% | 793,144 | -47.9% | 0.00% | 0.0% |
Q4 2019 | $7,322,000 | +63.0% | 1,522,484 | +105.4% | 0.00% | 0.0% |
Q3 2019 | $4,492,000 | -4.1% | 741,289 | +2.6% | 0.00% | 0.0% |
Q2 2019 | $4,686,000 | -3.7% | 722,160 | +5.2% | 0.00% | 0.0% |
Q1 2019 | $4,868,000 | -15.8% | 686,727 | -42.3% | 0.00% | 0.0% |
Q4 2018 | $5,780,000 | +39.2% | 1,189,614 | +110.6% | 0.00% | 0.0% |
Q3 2018 | $4,152,000 | +22.0% | 564,905 | +5.9% | 0.00% | 0.0% |
Q2 2018 | $3,403,000 | +22.3% | 533,503 | +4.3% | 0.00% | 0.0% |
Q1 2018 | $2,783,000 | +31.1% | 511,753 | +0.5% | 0.00% | 0.0% |
Q4 2017 | $2,122,000 | -52.2% | 508,997 | +10.5% | 0.00% | -50.0% |
Q3 2017 | $4,436,000 | -16.6% | 460,677 | +2.5% | 0.00% | 0.0% |
Q2 2017 | $5,319,000 | +7.5% | 449,658 | +16.5% | 0.00% | 0.0% |
Q1 2017 | $4,947,000 | +13.8% | 385,994 | +8.7% | 0.00% | 0.0% |
Q4 2016 | $4,346,000 | +14.8% | 355,090 | +10.6% | 0.00% | 0.0% |
Q3 2016 | $3,787,000 | +40.0% | 321,021 | +3.2% | 0.00% | +100.0% |
Q2 2016 | $2,705,000 | +79.5% | 311,076 | +8.7% | 0.00% | 0.0% |
Q1 2016 | $1,507,000 | -28.1% | 286,064 | +5.8% | 0.00% | 0.0% |
Q4 2015 | $2,097,000 | +4.6% | 270,327 | +6.1% | 0.00% | 0.0% |
Q3 2015 | $2,005,000 | -12.5% | 254,830 | +0.7% | 0.00% | 0.0% |
Q2 2015 | $2,292,000 | -26.2% | 253,060 | +5.8% | 0.00% | -50.0% |
Q1 2015 | $3,104,000 | +4.0% | 239,149 | +9.0% | 0.00% | 0.0% |
Q4 2014 | $2,985,000 | +62.9% | 219,326 | +7.3% | 0.00% | +100.0% |
Q3 2014 | $1,832,000 | -33.2% | 204,332 | +0.8% | 0.00% | -50.0% |
Q2 2014 | $2,743,000 | +39.2% | 202,774 | +2.3% | 0.00% | +100.0% |
Q1 2014 | $1,970,000 | -23.5% | 198,206 | +2.5% | 0.00% | -50.0% |
Q4 2013 | $2,574,000 | +29.2% | 193,390 | +17.9% | 0.00% | 0.0% |
Q3 2013 | $1,993,000 | +62.7% | 164,017 | +38.5% | 0.00% | +100.0% |
Q2 2013 | $1,225,000 | – | 118,434 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |